NDC55513-0222-01 — ROMIPLOSTIN FOR INJECTION

✓ Government record, cited

— · COMPONENT

PRODUCT OVERVIEW

NDC55513-0222-01: ROMIPLOSTIN FOR INJECTION.

The ROMIPLOSTIN FOR INJECTION is a the manufacturer industrial component. Key specifications include administration: SUBCUTANEOUS, primary_container_type: VIAL, protective_storage_feature: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING, primary_container_content_quantity: 500.0 MICROGRAMS OF ACTIVE INGREDIENT, part_name_assigned_by_controlling_agency: ROMIPLOSTIM, NPLATE, 500MCG SDV 1ML VIAL. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-697-1709, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS

NDC55513-0222-01

NSN: 6505-01-697-1709
FSC: 6505 — Drugs and Biologicals
CAGE: 0JVZ6 — AMGEN INC. (USA)

SPECIFICATIONS

administration	SUBCUTANEOUS
special_features	500MCG SDV; 1 ML VIAL. NPLATE ROMIPLOSTIM IS A THROMBOPOIETIN RECEPTOR AGONIST INDICATED FOR THE TREATMENT OF THROMBOCYTOPENIA. STORE AT 2 TO 8C. PROTECT FROM LIGHT. DO NOT FREEZE.
primary_container_type	VIAL
protective_storage_feature	REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING
total_primary_container_quantity	1
primary_container_content_quantity	500.0 MICROGRAMS OF ACTIVE INGREDIENT
part_name_assigned_by_controlling_agency	ROMIPLOSTIM, NPLATE, 500MCG SDV 1ML VIAL
NSN	6505-01-697-1709

COMPONENT DIAGRAM

KEY FEATURES

•

ADMINISTRATION: SUBCUTANEOUS

•

PRIMARY CONTAINER CONTENT QUANTITY: 500.0 MICROGRAMS OF ACTIVE INGREDIENT

•

PRIMARY CONTAINER TYPE: VIAL

•

PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING

•

TOTAL PRIMARY CONTAINER QUANTITY: 1

TECHNICAL CHARACTERISTICS

ADMINISTRATION	SUBCUTANEOUS
PRIMARY CONTAINER CONTENT QUANTITY	500.0 MICROGRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE	VIAL
SPECIAL FEATURES	500MCG SDV; 1 ML VIAL. NPLATE ROMIPLOSTIM IS A THROMBOPOIETIN RECEPTOR AGONIST INDICATED FOR THE TREATMENT OF THROMBOCYTOPENIA. STORE AT 2 TO 8C. PROTECT FROM LIGHT. DO NOT FREEZE.
PROTECTIVE STORAGE FEATURE	REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING
PART NAME ASSIGNED BY CONTROLLING AGENCY	ROMIPLOSTIM, NPLATE, 500MCG SDV 1ML VIAL
TOTAL PRIMARY CONTAINER QUANTITY	1

OTHER ITEMS IN FSC 6505 — Drugs and Biologicals

Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.

6505-00-000-0073 6505-00-000-0110 6505-00-000-0134 6505-00-000-0135 6505-00-001-3344 6505-00-001-3345 6505-00-001-3346 6505-00-001-3347

SUBSTITUTES & CROSS-REFERENCES 2

1598733Reference document

Same NSN cross-reference

Reference document — Secondary reference

6505NCM217322Reference document

Same NSN cross-reference

Reference document — Secondary reference

LIFECYCLE

NSN statusActive· U.S. Government catalog

Shelf-life managedNo demilitarization required

Ready to buy NDC55513-0222-01?

Compare prices from verified sellers on eBay

Buy on eBay →

As an eBay Partner, PartsTable may earn a commission. Your price is not affected.

FREQUENTLY ASKED QUESTIONS

What is NDC55513-0222-01?

NDC55513-0222-01 is a ROMIPLOSTIN FOR INJECTION.

What parts can replace NDC55513-0222-01?

There are 2 known substitutes for NDC55513-0222-01: 1598733, 6505NCM217322. Substitute compatibility should be verified for your specific system.

What is the NSN for NDC55513-0222-01?

NDC55513-0222-01 is cataloged in the U.S. Government catalog under NSN 6505-01-697-1709. This indicates validated use in U.S. government and defense supply chains.

Community Feedback

NDC55513-0222-01 — ROMIPLOSTIN FOR INJECTION

Request a Quote — NDC55513-0222-01